Group 1 - The core point of the news is that Meihao Medical experienced a decline in stock price, dropping by 5.22% to 25.23 CNY per share, with a trading volume of 348 million CNY and a turnover rate of 8.65%, resulting in a total market capitalization of 14.353 billion CNY [1] - Meihao Medical, established on July 15, 2010, and listed on October 12, 2022, specializes in the design, development, manufacturing, and sales of precision components and products for medical devices [1] - The revenue composition of Meihao Medical includes: 59.48% from home respiratory machine components, 14.61% from home and consumer electronics components, 10.33% from other medical product components, 8.16% from cochlear implant components, 5.63% from precision molds and automation equipment, 1.09% from other categories, and 0.70% from proprietary products [1] Group 2 - From the perspective of fund holdings, one fund under Agricultural Bank of China Asset Management has a significant position in Meihao Medical, with a reduction of 4,060 shares in the second quarter, holding a total of 13,300 shares, which represents 0.52% of the fund's net value, making it the third-largest holding [2] - The Agricultural Bank of China Asset Management's fund, named Agricultural Bank of China Ruiyun Gain 6-Month Holding Mixed A (017624), was established on March 21, 2023, with a latest scale of 27.553 million CNY, and has achieved a year-to-date return of 4.71% [2] - The fund's performance rankings indicate it is positioned 6,817 out of 8,194 in year-to-date returns and 6,984 out of 7,962 in one-year returns, with an overall return of 9.72% since inception [2]
美好医疗股价跌5.22%，农银汇理基金旗下1只基金重仓，持有1.33万股浮亏损失1.85万元